New Similarity Search Based Glioma Grading
Overview
Authors
Affiliations
Introduction: MR-based differentiation between low- and high-grade gliomas is predominately based on contrast-enhanced T1-weighted images (CE-T1w). However, functional MR sequences as perfusion- and diffusion-weighted sequences can provide additional information on tumor grade. Here, we tested the potential of a recently developed similarity search based method that integrates information of CE-T1w and perfusion maps for non-invasive MR-based glioma grading.
Methods: We prospectively included 37 untreated glioma patients (23 grade I/II, 14 grade III gliomas), in whom 3T MRI with FLAIR, pre- and post-contrast T1-weighted, and perfusion sequences was performed. Cerebral blood volume, cerebral blood flow, and mean transit time maps as well as CE-T1w images were used as input for the similarity search. Data sets were preprocessed and converted to four-dimensional Gaussian Mixture Models that considered correlations between the different MR sequences. For each patient, a so-called tumor feature vector (= probability-based classifier) was defined and used for grading. Biopsy was used as gold standard, and similarity based grading was compared to grading solely based on CE-T1w.
Results: Accuracy, sensitivity, and specificity of pure CE-T1w based glioma grading were 64.9%, 78.6%, and 56.5%, respectively. Similarity search based tumor grading allowed differentiation between low-grade (I or II) and high-grade (III) gliomas with an accuracy, sensitivity, and specificity of 83.8%, 78.6%, and 87.0%.
Conclusion: Our findings indicate that integration of perfusion parameters and CE-T1w information in a semi-automatic similarity search based analysis improves the potential of MR-based glioma grading compared to CE-T1w data alone.
Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.
Brendle C, Hempel J, Schittenhelm J, Skardelly M, Tabatabai G, Bender B Clin Neuroradiol. 2017; 28(3):421-428.
PMID: 28488024 DOI: 10.1007/s00062-017-0590-z.
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.
Lopci E, Riva M, Olivari L, Raneri F, Soffietti R, Piccardo A Eur J Nucl Med Mol Imaging. 2017; 44(7):1155-1164.
PMID: 28110346 DOI: 10.1007/s00259-017-3618-3.
Cuccarini V, Erbetta A, Farinotti M, Cuppini L, Ghielmetti F, Pollo B J Neurooncol. 2015; 126(2):279-88.
PMID: 26468137 DOI: 10.1007/s11060-015-1960-5.
Kang H, Xiao H, Chen J, Tan Y, Chen X, Xie T AJNR Am J Neuroradiol. 2015; 37(1):51-7.
PMID: 26381565 PMC: 7960212. DOI: 10.3174/ajnr.A4477.
Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.
Hochberg F, Atai N, Gonda D, Hughes M, Mawejje B, Balaj L Expert Rev Mol Diagn. 2014; 14(4):439-52.
PMID: 24746164 PMC: 5451266. DOI: 10.1586/14737159.2014.905202.